glp 1 mimetic Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors GLP-1 receptor agonists for individualized

Research published in Plastic and Reconstructive Surgery demonstrates that topical glutathione treatment in ischemic wound models significantly reduces oxidative stress and reestablishes the matrix metalloproteinase-1/tissue inhibitor of metalloproteinase-1 (MMP-1/TIMP-1) ratio, enabling adequate extracellular matrix production and reepithelization

Some smoothies use alternatives like stevia

phytoactive Se generally exists as selenomethionine, which is biotransformed to synthesize specific selenoproteins and is not directly toxic even at a high doses (109)

KFF Health tracking poll May 2024: The publics use and views of GLP-1 drugs

doi:10.3390/ijms20102428

The community includes researchers running various stack combinations who share real-world observations